Postdoc in liver genomics and bioinformatics
We are seeking a highly qualified postdoc fellow experienced in bioinformatics/biostatistics methodologies and interested in their application for clinical outcome prediction, disease classification, and therapeutic target discovery in liver and other diseases. The candidate will work on variety of large-scale data derived from high-throughput genomics assays such as sequencing and microarray. There will be ample opportunities to publish via close daily interaction with experienced bioinformatics, cancer biology, and clinical experts at the Institute and numerous national and international collaborators. The lab is a part of the Tisch Cancer Institute in the newly launched beautiful Center for Science and Medicine building, housing cutting-edge research facilities and world-class scientists, located in Upper East Side of Manhattan.
1. Nakagawa, et al. Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition. Cancer Cell. 30;879-890, 2016.
2. Goossens, et al. Cost-effectiveness of risk score-stratified hepatocellular carcinoma screening in patients with cirrhosis. Clin Transl Gastroenterol. 2017 Jun 22;8(6):e101.
3. Finkin, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015 Dec;16(12):1235-44.
4. Hoshida, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008 Nov 6;359(19):1995-2004.